ZURICH (Reuters) - A patient with H1N1 influenza in Denmark showed resistance to Roche Holding AG's Tamiflu, the main antiviral flu drug, a company executive said on Monday.
Reuters: Top News, Reuters
Mon, 06/29/2009 - 9:21am
ZURICH (Reuters) - A patient with H1N1 influenza in Denmark showed resistance to Roche Holding AG's Tamiflu, the main antiviral flu drug, a company executive said on Monday.